P33 Chicago published findings showing that the gap between eligible patients for genetic testing or enhanced screening under national guidelines and completed testing, appointments, and follow-up is significant and depends on cancer type, care setting, and follow-up support.
Published
Signal category
Research & Knowledge
Quote
“That’s not a story about patients declining care. It’s a story about everything that happens, or doesn’t, between a guideline and a completed test: referrals that never get scheduled, prior authorizations that stall out, follow-up calls that don’t happen, patients who raise their hand and then don’t hear back in time.”
— Feyi Ayodele|P33 Chicago team
Company
P33 Chicago
P33 is on a mission to transform Chicago into a tier one technology and innovation hub driving inclusive economic growth
- Industry
- Civic and Social Organizations
- Location
- Chicago, US
- Company size
- 41 employees
P33 is on a mission to transform Chicago into a tier one technology and innovation hub driving inclusive economic growth. P33 was founded in 2019 by civic and business leaders focused on cultivating world-class startups, emerging industries, and tech opportunities for all. To facilitate significant economic growth, P33 acts as a catalyst between Chicago stakeholders and the global tech community.
Founded 2018